Literature DB >> 29124524

High comorbidity, measured by the Charlson Comorbidity Index, associates with higher 1-year mortality risks in elderly patients experiencing a first acute heart failure hospitalization.

Francesc Formiga1, Rafael Moreno-Gonzalez2, David Chivite2, Jonathan Franco3, Abelardo Montero2, Xavier Corbella2,4.   

Abstract

BACKGROUND: Comorbidity is related to poor health results in chronic heart failure (HF). AIMS: The purpose of the study was to assess whether a high Charlson Comorbidity Index score (CCI) relates to 1 year mortality after a first hospitalization for acute HF (AHF).
METHODS: We reviewed the medical records of 897 patients > 65 years of age admitted within a two-year period because of a first episode of AHF. We analyzed two groups: low (CCI ≤ 2) and high (CCI > 2) comorbidity.
RESULTS: Patients' mean CCI was 2.2 ± 1.7; 344 patients (38.35%) had a CCI > 2. 1-year all-cause mortality rate in the high comorbidity group was 32.6%, worse than that among low comorbidity group patients (23.7%, p = 0.002). Cox multivariate analysis identified a CCI > 2 as an independent risk factor for 1-year mortality (p = 0.002; HR: 1.525; CI 95% 1.161-2.003), along with older age, history of arterial hypertension, and higher admission heart rate and serum potassium values. Analyzing CCI as a continuous variable, the association remained is also significant (p = 0.0001; HR 1.145; CI 95% 1.069-1.854).
CONCLUSIONS: Higher global comorbidity (CCI > 2) at the time of a first hospitalization because of AHF is an independent predictor of mid-term post-discharge mortality among elderly HF patients.

Entities:  

Keywords:  Comorbidity; Heart failure; Hospitalization; Mortality

Mesh:

Year:  2017        PMID: 29124524     DOI: 10.1007/s40520-017-0853-1

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  14 in total

1.  Prognostic influence of prior chronic obstructive pulmonary disease in patients admitted for the first time because of acute heart failure: reply.

Authors:  Francesc Formiga; Karine Luz Londoño; David Chivite
Journal:  Intern Emerg Med       Date:  2018-05-09       Impact factor: 3.397

2.  Time-pattern of adverse outcomes after an infection-triggered acute heart failure decompensation and the influence of early antibiotic administration and hospitalisation: results of the PAPRICA-3 study.

Authors:  Òscar Miró; Koji Takagi; Étienne Gayat; Víctor Gil; Pere Llorens; Francisco J Martín-Sánchez; Javier Jacob; Pablo Herrero-Puente; Rosa Escoda; María Pilar López-Díez; Amparo Valero; Marta Fuentes; José M Garrido; Eva Salvo; Miguel A Rizzi; Alfons Aguirre; Lissete Travería Bécquer; Alberto Domínguez-Rodríguez; Joan Padrosa; Gemma Martínez; Mattia Arrigo; Yonathan Freund; Alexandre Mebazaa
Journal:  Clin Res Cardiol       Date:  2019-04-29       Impact factor: 5.460

3.  The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.

Authors:  Monica S Thakar; Larisa Broglie; Brent Logan; Andrew Artz; Nancy Bunin; Lauri M Burroughs; Caitrin Fretham; David A Jacobsohn; Alison W Loren; Joanne Kurtzberg; Caridad A Martinez; Shin Mineishi; Adam S Nelson; Ann Woolfrey; Marcelo C Pasquini; Mohamed L Sorror
Journal:  Blood       Date:  2018-12-13       Impact factor: 22.113

4.  Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury.

Authors:  Marwan Ghabril; Jiezhun Gu; Lindsay Yoder; Laura Corbito; Amit Ringel; Christian D Beyer; Raj Vuppalanchi; Huiman Barnhart; Paul H Hayashi; Naga Chalasani
Journal:  Gastroenterology       Date:  2019-07-11       Impact factor: 22.682

5.  Predisposing and precipitating factors for delirium in neurology: a prospective cohort study of 1487 patients.

Authors:  Carl Moritz Zipser; Jeremy Deuel; Jutta Ernst; Maria Schubert; Michael Weller; Roland von Känel; Soenke Boettger
Journal:  J Neurol       Date:  2019-09-13       Impact factor: 4.849

6.  Profile of Obesity and Comorbidities in Elderly Patients with Heart Failure.

Authors:  Alexandra Dădârlat-Pop; Adela Sitar-Tăut; Dumitru Zdrenghea; Bogdan Caloian; Raluca Tomoaia; Dana Pop; Anca Buzoianu
Journal:  Clin Interv Aging       Date:  2020-04-21       Impact factor: 4.458

7.  Factors associated with death in bedridden patients in China: A longitudinal study.

Authors:  Jing Cao; Tiantian Wang; Zhen Li; Ge Liu; Ying Liu; Chen Zhu; Jing Jiao; Jiaqian Li; Fangfang Li; Hongpeng Liu; Huaping Liu; Baoyun Song; Jingfen Jin; Yilan Liu; Xianxiu Wen; Shouzhen Cheng; Xia Wan; Xinjuan Wu
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

8.  Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co-morbid burden in acute decompensated heart failure.

Authors:  Kiyomi Kayama; Takahisa Yamada; Shunsuke Tamaki; Tetsuya Watanabe; Takashi Morita; Yoshio Furukawa; Masato Kawasaki; Atsushi Kikuchi; Tsutomu Kawai; Masahiro Seo; Jun Nakamura; Masatsugu Kawahira; Masatake Fukunami
Journal:  ESC Heart Fail       Date:  2021-01-12

9.  Serum albumin and FT3/FT4 ratio as additional co-morbidity parameters to predict mortality as a new approach: The Haseki Scoring Index (updated Charlson Comorbidity Index).

Authors:  Betul Cavusoglu Turker; Fatih Turker; Suleyman Ahbab; Emre Hoca; Meryem Tahmaz; Hayriye Esra Ataoğlu
Journal:  PLoS One       Date:  2022-03-14       Impact factor: 3.240

10.  Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease.

Authors:  Scott Coppel; Karan Mathur; Burcin Ekser; Kavish R Patidar; Eric Orman; Archita P Desai; Eduardo Vilar-Gomez; Chandrashekhar Kubal; Naga Chalasani; Lauren Nephew; Marwan Ghabril
Journal:  BMC Gastroenterol       Date:  2020-09-16       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.